Skip to main content
. 2023 Feb 3;278(3):e641–e649. doi: 10.1097/SLA.0000000000005813

TABLE 3.

Outcome of Propensity-matched Cohorts (<70 yr vs ≥70 yr)

Statistic <70 yr ≥70 yr P
Primary outcome
CLAD-free survival; % (95% CI) 0.41
 1 yr 84.2 (72.5; 91.2) 78.9 (66.9; 86.9)
 3 yr 68.6 (55.2; 78.7) 60.8 (47.1; 71.9)
 5 yr 59.2 (44.6; 71.1) 51.5 (37.3; 64.0)
Patient survival; % (95% CI) 0.72
 1 yr 90.6 (80.3; 95.7) 85.0 (73.9; 91.7)
 3 yr 80.4 (68.1; 88.4) 75.9 (63.1; 84.8)
 5 yr 73.1 (58.9; 83.1) 73.6 (60.2; 83.1)
PGD; n/N (%) 0.85
 Any PGD-3 20/69 (28.99) 18/69 (26.09)
 No PGD-3 49/69 (71.01) 51/69 (73.91)
Secondary outcome
Bronchoscopy; n/N (%) 1.00
 Abnormal 12/69 (17.39) 13/69 (18.84)
 Normal 57/69 (82.61) 56/69 (81.16)
ICU stay (d); median (IQR) 6.0 (4.0–13.0) 7.0 (4.0–12.0) 0.46
Hospital stay (d); median (IQR) 29.0 (25.0–46.0) 32.0 (23.5–51.0) 0.10
Reintervention; n/N (%) 0.10
 No 58/69 (84.06) 49/69 (71.01)
 Yes 11/69 (15.94) 20/69 (28.99)
Spirometry; median (IQR)
 FEV1 (liter) 0.25
 3 yr 2.35 (1.78–2.69) 1.98 (1.76–2.70)
 5 yr 2.22 (1.72–2.72) 2.08 (1.60–2.30)
 FVC (liter) 0.79
 3 yr 2.92 (2.59–3.49) 2.88 (2.47–3.63)
 5 yr 2.72 (2.48–3.13) 2.65 (2.38–3.03)
 TLC (liter) 0.88
 3 yr 4.66 (4.11–5.30) 4.45 (3.93–5.63)
 5 yr 4.47 (3.89–5.10) 4.40 (3.93–4.84)
DLCO (mmol/min/kPa) 0.16
 3 yr 4.32 (3.76–5.08) 4.22 (3.30–4.98)
 5 yr 4.15 (3.50–5.07) 3.83 (3.05–4.87)
Time on ventilator (d); median (IQR) 2.0 (1.0–5.0) 2.0 (1.0–4.0) 0.82

DLCO indicates diffusing capacity for carbon monoxide; FVC, forced vital capacity; IQR, interquartile range; TLC, total lung capacity.